Antiviral Treatment in Patients with Advanced Hcv Cirrhosis Using Sofosbuvir and Ledipasvir/Daclatasvir with or without Ribavirin - 6 and 12 Month Outcomes Compared to Untreated Patients

Subjects

Subjects :

Ledipasvir
medicine.medical_specialty
Daclatasvir
Cirrhosis
Hepatology
Sofosbuvir
business.industry
Ribavirin
medicine.disease
Gastroenterology
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
chemistry
030220 oncology & carcinogenesis
Internal medicine
medicine
030211 gastroenterology & hepatology
In patient
Antiviral treatment
business
medicine.drug

Details

ISSN :

01688278

Volume :

64

Database :

OpenAIRE

Journal :

Journal of Hepatology

Accession number :

edsair.doi...........51c59d090336889cfe5c2d79e051fa0a

Full Text :

https://doi.org/10.1016/s0168-8278(16)01699-8